Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TIPRL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | REV1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | KRTAP17-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | CELF5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PRUNE2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FKBPL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | OTUD7A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MEPE | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | FAAP100 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | COX15 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |